Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorna Rodriguez-Rodriguez

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Public Health|August 7, 2025
Uncovering multilevel drivers of cancer disparities among Latinos in the United StatesAmelie G Ramirez, Edgar Munoz, Lorna Rodriguez-Rodriguez, et al.
Gynecologic Oncology|March 27, 2016
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancersLorna Rodriguez-Rodriguez, Kim M Hirshfield, Veronica Rojas, et al.
Journal of Clinical Medicine|September 5, 2020
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge ResearchEdward Wenge Wang, Christina Hsiao Wei, Sariah Liu, et al.
Journal for Immunotherapy of Cancer|April 5, 2024
Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancerAntons Martincuks, Chunyan Zhang, Theresa Austria, et al.
Frontiers in Public Health|November 14, 2025
Correction: Uncovering multilevel drivers of cancer disparities among Latinos in the United StatesAmelie G Ramirez, Edgar Munoz, Lorna Rodriguez-Rodriguez, et al.
JCO Precision Oncology|September 25, 2018
Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing DataHossein Khiabanian, Kim M Hirshfield, Mendel Goldfinger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2022
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancerEugenia Girda, June Hou, David Nelson, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Blood|April 22, 2018
Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimensEric A Severson, Gregory M Riedlinger, Caitlin F Connelly, et al.
Annals of Surgical Oncology|July 27, 2023
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USAMustafa Raoof, Richard L Whelan, Kevin M Sullivan, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Public Health|August 7, 2025
Uncovering multilevel drivers of cancer disparities among Latinos in the United StatesAmelie G Ramirez, Edgar Munoz, Lorna Rodriguez-Rodriguez, et al.
Gynecologic Oncology|March 27, 2016
Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancersLorna Rodriguez-Rodriguez, Kim M Hirshfield, Veronica Rojas, et al.
Journal of Clinical Medicine|September 5, 2020
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge ResearchEdward Wenge Wang, Christina Hsiao Wei, Sariah Liu, et al.
Journal for Immunotherapy of Cancer|April 5, 2024
Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancerAntons Martincuks, Chunyan Zhang, Theresa Austria, et al.
Frontiers in Public Health|November 14, 2025
Correction: Uncovering multilevel drivers of cancer disparities among Latinos in the United StatesAmelie G Ramirez, Edgar Munoz, Lorna Rodriguez-Rodriguez, et al.
JCO Precision Oncology|September 25, 2018
Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing DataHossein Khiabanian, Kim M Hirshfield, Mendel Goldfinger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2022
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancerEugenia Girda, June Hou, David Nelson, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Blood|April 22, 2018
Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimensEric A Severson, Gregory M Riedlinger, Caitlin F Connelly, et al.
Annals of Surgical Oncology|July 27, 2023
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USAMustafa Raoof, Richard L Whelan, Kevin M Sullivan, et al.
Pageof 7